Salmeterol provides prolonged protection against exercise-induced bronchoconstriction in a majority of subjects with mild, stable asthma

In patients with asthma, exercise-induced symptoms are well recognized and frequently limiting. Currently available β 2-receptor agonists have a short duration of action and breakthrough symptoms may occur. We studied the efficacy of the recently developed long acting inhaled β 2-agonist salmeterol...

Ausführliche Beschreibung